Results 21 to 30 of about 20,498,806 (233)

High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials. [PDF]

PLoS ONE, 2013
To compare the efficacy and safety of high dose rate (HDR) and low dose rate (LDR) brachytherapy in treating early-stage oral cancer.A systematic search of MEDLINE, EMBASE and Cochrane Library databases, restricted to English language up to June 1, 2012,
Zhenxing Liu, Shengyun Huang, Dongsheng Zhang   +2 more
doaj   +1 more source

Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation

Radiation Oncology, 2021
Background Centrally located lung tumors present treatment challenges given their proximity to mediastinal structures including the central airway, esophagus, major vessels, and heart. Therapeutic options can be limited for medically inoperable patients,
Stephanie M. Yoon, Robert Suh, Fereidoun Abtin, Drew Moghanaki, Scott Genshaft, Mitchell Kamrava, Alexandra Drakaki, Sandy Liu, Puja Venkat, Alan Lee, Albert J. Chang   +10 more
doaj   +1 more source

Skin marker for MR-only surface high-dose-rate brachytherapy [PDF]

Journal of Contemporary Brachytherapy
Evangelia Kaza, Phillip M. Devlin, Desmond O’Farrell, Ivan Buzurovic   +3 more
doaj   +2 more sources

High dose rate brachytherapy for oral cancer [PDF]

Journal of Radiation Research, 2012
Brachytherapy results in better dose distribution compared with other treatments because of steep dose reduction in the surrounding normal tissues. Excellent local control rates and acceptable side effects have been demonstrated with brachytherapy as a sole treatment modality, a postoperative method, and a method of reirradiation.
YamazakI, Hideya, Yoshida, Ken, Yoshioka, Yasuo, Shimizutani, Kimishige, Furukawa, Souhei, Koizumi, Masahiko, Ogawa, Kazuhiko   +6 more
openaire   +2 more sources

High dose rate brachytherapy as monotherapy for localised prostate cancer : a hypofractionated two-implant approach in 351 consecutive patients [PDF]

, 2013
BACKGROUND: To report the clinical outcome of high dose rate brachytherapy as sole treatment for clinically localised prostate cancer. METHODS: Between March 2004 and January 2008, a total of 351 consecutive patients with clinically localised prostate ...
Markus Ratka, Milickovic, Natasa, Nikolaos Zamboglou, Dimos Baltas, Zamboglou, Nikolaos, Ratka, Markus, Natasa Milickovic, Chatzikonstantinou, Georgios, Tunn, Ulf W., Baltas, Dimos, Tselis, Nikolaos, Georgios Chatzikonstantinou, Nikolaos Tselis, Ulf W Tunn   +13 more
core   +1 more source

Optically stimulated luminescent dosimetry for high dose rate brachytherapy

Frontiers in Oncology, 2012
Purpose: The objective was to determine whether optically stimulated luminescent dosimeters (OSLDs) were appropriate for in vivo measurements in high dose rate brachytherapy. In order to make this distinction, three dosimetric characteristics were tested:
Christopher Jason Tien, Robert eEbeling, Jessica R Hiatt, Bruce eCurran, Edward eSternick   +4 more
doaj   +1 more source

Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques

Advances in Radiation Oncology, 2023
Purpose: Quantification of integral radiation dose delivered during treatment for prostate cancer is lacking. We performed a comparative quantification of dose to nontarget body tissues delivered via 4 common radiation techniques: conventional volumetric
Vincent P. Grzywacz, MD, Jessica D. Arden, MD, PhD, Nikhil P. Mankuzhy, MD, Gary S. Gustafson, MD, Evelyn A. Sebastian, BS, Veronica L. Abbott, MS, Kailee J. Walters, MS, Julie A. Puzzonia, MS, Amy S. Limbacher, BS, Jason M. Hafron, MD, Daniel J. Krauss, MD   +10 more
doaj   +1 more source

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center

, 2021
Purpose: Until now, most long-term results for brachytherapy only has been published for low-dose-rate (LDR) seeds. Due to radiobiology reasons, high-dose-rate (HDR) mono-brachytherapy is of growing interest.
Bengt Johansson, Staby Olsén, Johan,, Leif Karlsson, Erik Lundin, Bo Lennernäs, Lundin, Erik,, Lennernäs, Bo,, Karlsson, Leif,, Johan Staby Olsén, Johansson, Bengt,   +9 more
core   +1 more source

Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature [PDF]

, 2016
Purpose: The incidence of non-melanoma skin cancer (NMSC) has been increasing over the past 30 years. There are different treatment options and surgical excision is the most frequent treatment due to its low rates of recurrence.
Rembielak, A., Manfredi, B., Pasqualetti, F., Paiar, F., Laliscia, C., Laliscia, Concetta, ORLANDI, FRANCESCA, Morganti, R., Fabrini, Maria Grazia, Concetta Laliscia, Francesco Pasqualetti, Ursino, S., Francesca Orlandi, PAIAR, FABIOLA, Agata Rembielak, Maria Grazia Fabrini, Bruno Manfredi, Stefano Ursino, PASQUALETTI, FRANCESCO, DELISHAJ, DURIM, Durim Delishaj, Manfredi, Bruno, URSINO, STEFANO, Fabiola Paiar, Delishaj, D., Riccardo Morganti, Orlandi, F., Rembielak, Agata, Morganti, Riccardo, Fabrini, M.G.   +29 more
core   +2 more sources

Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials

Journal of Experimental & Clinical Cancer Research, 2009
Background The literature supporting high-dose rate brachytherapy (HDR) in the treatment of cervical carcinoma derives primarily from retrospective series.
Stefano Eduardo J, Manta Gustavo B, Viani Gustavo A, de Fendi Ligia I   +3 more
doaj   +1 more source